phenytoin has been researched along with Abdominal Epilepsy in 202 studies
Excerpt | Relevance | Reference |
---|---|---|
"To compare the effectiveness of monotherapy clobazam (CLB) to carbamazepine (CBZ) and phenytoin (PHT) in children with epilepsy." | 9.08 | Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. ( , 1998) |
"A double-blind cross-over trial between pheneturide and phenytoin in ninety-four outpatients with epilepsy is described." | 9.05 | A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial. ( Engler, C; English, JR; Fry, DE; Gawel, MJ; Gibberd, FB; Page, NG; Park, DM; Rose, FC; Scott, G, 1982) |
"To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset focal or generalized seizures." | 8.98 | Clobazam monotherapy for focal or generalized seizures. ( Anand, V; Arya, R; Garg, SK; Giridharan, N, 2018) |
"To review the time to withdrawal, remission and first seizure of phenytoin compared to valproate when used as monotherapy in people with partial onset seizures or generalised tonic-clonic seizures (with or without other generalised seizure types)." | 8.93 | Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2016) |
"To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset partial or generalized seizures." | 8.90 | Clobazam monotherapy for partial-onset or generalized-onset seizures. ( Anand, V; Arya, R; Garg, SK; Michael, BD, 2014) |
"To review the best evidence comparing phenobarbitone and phenytoin when used as monotherapy in participants with partial onset seizures or generalised tonic-clonic seizures with or without other generalised seizure types." | 8.89 | Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. ( Marson, AG; Nolan, SJ; Pulman, J; Tudur Smith, C, 2013) |
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in individuals with partial onset seizures or generalised onset tonic-clonic seizures with or without other generalised seizure types." | 8.89 | Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. ( Marson, AG; Nolan, SJ; Pulman, J; Tudur Smith, C, 2013) |
"To review the best evidence comparing oxcarbazepine and phenytoin when used as monotherapy in patients with epilepsy." | 8.83 | Oxcarbazepine versus phenytoin monotherapy for epilepsy. ( Marson, AG; Muller, M; Williamson, PR, 2006) |
"To review the effects of phenobarbitone compared to phenytoin when used as monotherapy in patients with partial onset seizures or generalized tonic-clonic seizures with or without other generalized seizure types." | 8.81 | Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. ( Marson, AG; Taylor, S; Tudur Smith, C; Williamson, PR, 2001) |
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in subjects with partial onset seizures, or generalized onset tonic-clonic seizures with or without other generalized seizure types." | 8.81 | Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. ( Marson, AG; Tudur Smith, C; Williamson, PR, 2001) |
"To evaluate whether the occurrence or severity of gingival hyperplasia is associated with liver function test results or phenytoin metabolism." | 7.74 | Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy. ( Hsiong, CH; Hu, OY; Hung, CC; Lin, CJ; Lin, MS; Liou, HH; Yen, MF, 2008) |
"INTRODUCTION-The aim of this case report is to present a 15-year follow-up of a patient with phenytoin (PHT) intoxication with unilateral gingival hyperplasia (GH)." | 7.69 | A 15-year follow-up of phenytoin-induced unilateral gingival hyperplasia: a case report. ( Tigaran, S, 1994) |
"Nine cases of childhood epilepsy manifesting motor convulsions uncontrolled despite high levels of phenytoin (PHT) were studied clinically and electroencephalographically." | 7.66 | Childhood epilepsy uncontrolled by phenytoin: clinical and electroencephalographic study. ( Iinuma, K; Onuma, A; Tada, K; Takamatsu, N, 1979) |
"Twenty-two patients with partial status epilepticus were treated with phenytoin (DPH) intravenously (mean daily dose: 18,6 +/- 7,3 mg/kg)." | 7.66 | [Use of intravenous phenytoin in treatment of partial status epilepticus (author's transl)]. ( Chauplannaz, G; Courjon, J; Ferry, S; Mauguière, F, 1981) |
" Dosing of phenytoin remains a challenge for all clinicians which increase the need for such reports." | 5.62 | Phenytoin-Induced Paradoxical Seizures and Blood Dyscrasias in a Patient Receiving Rapid Intravenous Infusion: A Case Report. ( Radhakrishnan, A; Sudarsan, P; Suresh, A; Varghese, R, 2021) |
"Adenosine is an inhibitor of neuronal activity in the brain." | 5.31 | Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. ( Aebischer, P; Boison, D; Déglon, N; Huber, A; Möhler, H; Padrun, V, 2001) |
"Phenytoin has been considered a possible cause of cerebellar degeneration, especially after clinical intoxication." | 5.29 | [Cerebellar atrophy and phenytoin poisoning. An MR study]. ( Aichner, F; Bauer, G; Birbamer, G; Felber, S; Luef, G; Marosi, M, 1993) |
"To compare the effectiveness of monotherapy clobazam (CLB) to carbamazepine (CBZ) and phenytoin (PHT) in children with epilepsy." | 5.08 | Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. ( , 1998) |
"A group of 51 patients with chronic cryptogenic or symptomatic localized epilepsy refractory to therapy with barbiturates underwent progressive substitution with phenytoin or carbamazepine, in standardized and randomized fashion." | 5.07 | Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function. ( Antoniuk, SA; Bigarella, MM; Bittencourt, PR; da Costa, JC; Doro, MP; Ferreira, AS; Fonseca, LC; Gonçalves e Silva, GE; Gorz, AM; Marcourakis, T, 1993) |
" All the patients had epilepsy that had previously been untreated, and had been randomly assigned to receive carbamazepine, phenytoin, or sodium valproate." | 5.06 | Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study. ( Callaghan, N; Garrett, A; Goggin, T, 1988) |
"A double-blind cross-over trial between pheneturide and phenytoin in ninety-four outpatients with epilepsy is described." | 5.05 | A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial. ( Engler, C; English, JR; Fry, DE; Gawel, MJ; Gibberd, FB; Page, NG; Park, DM; Rose, FC; Scott, G, 1982) |
"Eighty-eight patients with the onset of epilepsy in adult life were randomly allocated to treatment with sodium valproate (600 mg/day), or phenytoin (300 mg/day), and followed up for at least 12 months." | 5.05 | A comparison of phenytoin and valproate in previously untreated adult epileptic patients. ( Chadwick, DW; Rawlins, MD; Turnbull, DM; Weightman, D, 1982) |
"To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset focal or generalized seizures." | 4.98 | Clobazam monotherapy for focal or generalized seizures. ( Anand, V; Arya, R; Garg, SK; Giridharan, N, 2018) |
"To review the time to treatment failure, remission and first seizure of sodium valproate compared to phenytoin when used as monotherapy in people with focal onset seizures or generalised tonic-clonic seizures (with or without other generalised seizure types)." | 4.98 | Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nevitt, SJ; Tudur Smith, C; Weston, J, 2018) |
"To review the time to withdrawal, remission and first seizure of phenytoin compared to valproate when used as monotherapy in people with partial onset seizures or generalised tonic-clonic seizures (with or without other generalised seizure types)." | 4.93 | Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2016) |
"To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset partial or generalized seizures." | 4.90 | Clobazam monotherapy for partial-onset or generalized-onset seizures. ( Anand, V; Arya, R; Garg, SK; Michael, BD, 2014) |
"To review the best evidence comparing phenobarbitone and phenytoin when used as monotherapy in participants with partial onset seizures or generalised tonic-clonic seizures with or without other generalised seizure types." | 4.89 | Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. ( Marson, AG; Nolan, SJ; Pulman, J; Tudur Smith, C, 2013) |
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in individuals with partial onset seizures or generalised onset tonic-clonic seizures with or without other generalised seizure types." | 4.89 | Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. ( Marson, AG; Nolan, SJ; Pulman, J; Tudur Smith, C, 2013) |
"In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiepileptic drugs after a single seizure; monotherapy for partial epilepsy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs for drug-resistant partial epilepsy (allopurinol, eslicarbazepine, gabapentin, lacosamide, lamotrigine, levetiracetam, losigamone, oxcarbazepine, retigabine, tiagabine, topiramate, vigabatrin, or zonisamide); antiepileptic drug withdrawal for people with partial or generalised epilepsy who are in remission; behavioural and psychological treatments for partial or generalised epilepsy (biofeedback, cognitive behavioural therapy (CBT), educational programmes, family counselling, relaxation therapy (alone or plus behavioural modification therapy, yoga); and surgery for drug-resistant temporal lobe epilepsy ( lesionectomy, temporal lobectomy, vagus nerve stimulation as adjunctive therapy)." | 4.87 | Epilepsy (partial). ( Maguire, M; Marson, AG; Ramaratnam, S, 2011) |
"In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiepileptic drugs after a single seizure; monotherapy for partial epilepsy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs for drug-resistant partial epilepsy (allopurinol, eslicarbazepine, gabapentin, lacosamide, lamotrigine, levetiracetam, losigamone, oxcarbazepine, retigabine, tiagabine, topiramate, vigabatrin, or zonisamide); antiepileptic drug withdrawal for people with partial or generalised epilepsy who are in remission; behavioural and psychological treatments for partial or generalised epilepsy (biofeedback, cognitive behavioural therapy (CBT), educational programmes, family counselling, relaxation therapy (alone or plus behavioural modification therapy, yoga); and surgery for drug-resistant temporal lobe epilepsy ( lesionectomy, temporal lobectomy, vagus nerve stimulation as adjunctive therapy)." | 4.86 | Epilepsy (partial). ( Maguire, M; Marson, AG; Ramaratnam, S, 2010) |
"To review the best evidence comparing oxcarbazepine and phenytoin when used as monotherapy in patients with epilepsy." | 4.83 | Oxcarbazepine versus phenytoin monotherapy for epilepsy. ( Marson, AG; Muller, M; Williamson, PR, 2006) |
"To review the best evidence comparing phenytoin and valproate when used as monotherapy in subjects with partial onset seizures, or generalized onset tonic-clonic seizures with or without other generalized seizure types." | 4.81 | Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. ( Marson, AG; Tudur Smith, C; Williamson, PR, 2001) |
"To review the effects of phenobarbitone compared to phenytoin when used as monotherapy in patients with partial onset seizures or generalized tonic-clonic seizures with or without other generalized seizure types." | 4.81 | Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. ( Marson, AG; Taylor, S; Tudur Smith, C; Williamson, PR, 2001) |
"We present the case of a 77 year old man who had been treated for twenty years with phenytoin for partial crises secondary to a left frontal hematoma." | 4.80 | [Acute phenytoin poisoning secondary to an interaction with ticlopidine]. ( López-Ariztegui, N; Martín, M; Nevado, C; Ochoà, M; Sánchez-Migallón, MJ, 1998) |
"To evaluate whether the occurrence or severity of gingival hyperplasia is associated with liver function test results or phenytoin metabolism." | 3.74 | Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy. ( Hsiong, CH; Hu, OY; Hung, CC; Lin, CJ; Lin, MS; Liou, HH; Yen, MF, 2008) |
"From 100 consecutive epilepsy patients we selected those with phenytoin use for more than 2 months and with MRI scan available for volumetric studies." | 3.72 | Cerebellar volume and long-term use of phenytoin. ( Cendes, F; De Marcos, FA; Ghizoni, E; Kobayashi, E; Li, LM, 2003) |
" The second patient complained of impotence after a rash while taking phenytoin and carbamazepine." | 3.70 | Improved sexual function in three men taking lamotrigine for epilepsy. ( Carwile, ST; Husain, AM; Miller, PP; Radtke, RA, 2000) |
"INTRODUCTION-The aim of this case report is to present a 15-year follow-up of a patient with phenytoin (PHT) intoxication with unilateral gingival hyperplasia (GH)." | 3.69 | A 15-year follow-up of phenytoin-induced unilateral gingival hyperplasia: a case report. ( Tigaran, S, 1994) |
"39 adult patients with intractable epilepsy were successfully treated with high-dose monotherapy, using carbamazepine or phenytoin." | 3.68 | [High-dose monotherapy in intractable epilepsy]. ( Peng, SM; Wu, JZ, 1990) |
"Twenty-two patients with partial status epilepticus were treated with phenytoin (DPH) intravenously (mean daily dose: 18,6 +/- 7,3 mg/kg)." | 3.66 | [Use of intravenous phenytoin in treatment of partial status epilepticus (author's transl)]. ( Chauplannaz, G; Courjon, J; Ferry, S; Mauguière, F, 1981) |
"Nine cases of childhood epilepsy manifesting motor convulsions uncontrolled despite high levels of phenytoin (PHT) were studied clinically and electroencephalographically." | 3.66 | Childhood epilepsy uncontrolled by phenytoin: clinical and electroencephalographic study. ( Iinuma, K; Onuma, A; Tada, K; Takamatsu, N, 1979) |
"The case of a 19-year-old patient is reported who during treatment with phenytoin (5,5-dephenylhydantoin) developed a Stevens-Johnson syndrome." | 3.65 | [Stevens-Johnson syndrome as an early allergic reaction to diphenylhydantoin]. ( Marg, E, 1976) |
"Phenytoin is a prototypic drug prescribed for the treatment of a variety of seizure disorders." | 3.01 | Cutaneous Hypersensitivity Reaction After Phenytoin Therapy in a Neonate: A Case Report and Review of Literature Elucidating the Potential Pharmacological Plausibility and Preventive Strategies. ( Prabath, I; Rajendran, P; Rani, J, 2023) |
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%." | 2.82 | Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Cividini, S; Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C, 2022) |
"Gabapentin was started at 400 mg/day and was individually titrated to effective tolerable dose up to 2400 mg/day." | 2.69 | Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice. ( Bruni, J, 1998) |
"Carbamazepine or phenytoin was withdrawn over the next 4 weeks; then patients entered a 12-week monotherapy period." | 2.69 | An active-control trial of lamotrigine monotherapy for partial seizures. ( Chang, GY; Gilliam, F; Messenheimer, J; Nyberg, J; Risner, ME; Rudd, GD; Sackellares, JC; Vazquez, B, 1998) |
"The gabapentin dosage was titrated to effective tolerated dose up to 2400 mg/day." | 2.69 | Gabapentin as adjunctive therapy for partial seizures. ( Bruni, J, 1999) |
" After 1-month observation, the patients entered a 7-month treatment period that involved administration of placebo for 1 month followed by VGB at the initial dosage of 40 mg/kg/day, to be increased to 60 and 80 mg/kg/day at 2-month intervals if seizures persisted." | 2.68 | Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study. ( Buti, D; Cianchetti, C; Dalla Bernardina, B; Fontana, E; Fusco, L; Galeone, D; Gnanasakthy, A; Iudice, A; Torelli, D; Vigevano, F, 1995) |
"A 62-year-old woman, who frequently had numbness seizures in the right half of her body, is reported." | 2.67 | Pure sensory seizures. ( Fukunishi, I; Hosokawa, K; Kohira, I; Kugoh, T; Okudaira, A; Yamamoto, M, 1993) |
"Felbamate was statistically superior to placebo in seizure reduction, percent seizure reduction, and truncated percent seizure reduction." | 2.67 | Felbamate for partial seizures: results of a controlled clinical trial. ( Bertram, E; Cereghino, JJ; Dreifuss, FE; Drury, I; Graves, NM; Jacobs, MP; Leppik, IE; Pledger, GW; Santilli, N; Tsay, JY, 1991) |
"Ninety four patients of generalised and partial epilepsy were randomly assigned to treatment with sodium valproate (49 cases) or phenytoin (45 cases)." | 2.67 | Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy. ( Agarwala, RK; Mehrotra, TN; Rastogi, P; Singh, VS, 1991) |
"Decreased libido and impotence were more common in patients given primidone." | 2.66 | Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. ( Browne, TR; Collins, JF; Cramer, JA; Delgado-Escueta, AV; Mattson, RH; McCutchen, CB; McNamara, JO; Smith, DB; Treiman, DM; Williamson, PD, 1985) |
"Carbamazepine was compared with phenytoin in a double-blind study." | 2.65 | A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. ( Berger, JR; Bruni, J; Ramsay, RE; Wilder, BJ, 1983) |
"Carbamazepine is a current first-line treatment for partial onset seizures in the USA and Europe." | 2.55 | Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nevitt, SJ; Tudur Smith, C; Weston, J, 2017) |
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%." | 2.55 | Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017) |
"Epilepsy is a common neurological condition with a worldwide prevalence of around 1%." | 2.55 | Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017) |
"Carbamazepine is a current first line treatment for partial onset seizures in the USA and Europe." | 2.52 | Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2015) |
"We review the various forms of partial epilepsy that appear in childhood and adolescence, emphasizing the most common forms." | 2.39 | [The diagnosis and treatment of partial epilepsy in childhood and adolescence]. ( Martínez Bermejo, Z; Pascual-Castroviejo, I, 1996) |
"Neocortical focal seizures are characterized by motor jerks in one limb (Jacksonian type), head turning (adversive attack), or localized sensory manifestations, and limbic or psychomotor attacks by brief impairment of consciousness and often by motor automatisms." | 2.37 | [Therapy of brain-related minor seizures]. ( Hess, CW, 1988) |
" The latter must be compensated for by planned dosage increases to maintain therapeutic plasma steady-state levels during the first 2 or 3 months of treatment." | 2.37 | Carbamazepine efficacy in adults with partial and generalized tonic-clonic seizures. ( Rangel, R; Wilder, BJ, 1987) |
"Valproic acid is a new antiepileptic drug." | 2.36 | Valproic acid. Review of a new antiepileptic drug. ( Bruni, J; Wilder, BJ, 1979) |
"Drug treatment of status epilepticus is reviewed." | 2.36 | Drug therapy reviews: drug therapy of status epilepticus. ( Browne, TR, 1978) |
" Dosing of phenytoin remains a challenge for all clinicians which increase the need for such reports." | 1.62 | Phenytoin-Induced Paradoxical Seizures and Blood Dyscrasias in a Patient Receiving Rapid Intravenous Infusion: A Case Report. ( Radhakrishnan, A; Sudarsan, P; Suresh, A; Varghese, R, 2021) |
"Perampanel (PER) is a new antiepileptic drug (AED) with a novel mechanism of action." | 1.51 | Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy. ( Ishikawa, N; Kobayashi, M; Kobayashi, Y; Tani, H; Tateishi, Y, 2019) |
"Topiramate was more likely prescribed for those with comorbid headache or migraine (incident: 335 of 1251 [26." | 1.51 | Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. ( Faught, E; Fishman, J; Kalilani, L; Kim, H; Thurman, DJ, 2019) |
"Among those with Idiopathic Generalized Epilepsy (46%), generalized tonic clonic seizure was encountered in 74% and absence seizure was observed in 13%." | 1.39 | Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital. ( Chowdhury, AH; Chowdhury, RN; Ghose, SK; Habib, M; Haque, B; Hasan, AT; Hoque, A; Khan, SU; Mohammad, QD; Mondal, BA; Rahman, KM, 2013) |
"Epilepsy was confirmed in 58 cases." | 1.37 | [Epilepsy in elderly]. ( Kotov, AS; Rudakova, IG, 2011) |
" The observed cerebellar ataxia might be due to long-term administration of phenytoin." | 1.35 | [Case of juvenile myoclonic epilepsy misdiagnosed as simple partial seizure for more than 60 years]. ( Komori, T; Mizoi, Y; Shimazu, K; Sumita, N; Tamura, N; Yamamoto, T, 2009) |
"Chronic focal epilepsy was induced by injecting 25-50 ng of tetanus toxin or vehicle alone (controls) into the motor neocortex of rats." | 1.33 | Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat. ( Cock, HR; Nilsen, KE; Walker, MC, 2005) |
"We report a case of a patient with presyncope and prosthetic mitral valve dysfunction with intermittent flow obstruction." | 1.33 | [Mitral prosthetic valve and presyncope]. ( Aguilera Saborido, A; Arana Rueda, E; Florián Sanz, F; Gómez Navarro, C; López Pardo, F; Nevado Portero, J, 2005) |
" Likewise, PGB steady-state pharmacokinetic parameter values were similar among patients receiving CBZ, PHT, LTG, or VPA and, in general, were similar to those observed historically in healthy subjects receiving PGB alone." | 1.33 | Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. ( Alvey, CW; Bockbrader, HN; Brodie, MJ; Bron, NJ; Gibson, GL; Hounslow, NJ; Posvar, EL; Randinitis, EJ; Wesche, DL; Wilson, EA, 2005) |
"Adenosine is an inhibitor of neuronal activity in the brain." | 1.31 | Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. ( Aebischer, P; Boison, D; Déglon, N; Huber, A; Möhler, H; Padrun, V, 2001) |
"Epilepsy is a relatively common problem in children, adults and the elderly." | 1.30 | Treatment of the epileptic patient in the dental office. ( Haller, JS; Kennedy, BT, 1998) |
" Pharmacokinetic data and occurrence of AE were compared between the two groups at the time of the single-dose kinetic study, at the completion of the switchover to CBZ, and 4 weeks after discontinuation of the previous AED." | 1.30 | Rapid switchover to carbamazepine using pharmacokinetic parameters. ( Bourgeois, BF; Hasegawa, H; Hutson, P; Kanner, AM, 1998) |
"Idiopathic generalized epilepsy (IGE) was diagnosed in 12 cases and partial epilepsy (PE) in 23 cases." | 1.29 | Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs. ( Costelli, P; Fonzi, S; Galimberti, CA; Manni, R; Murialdo, G; Parodi, C; Polleri, A; Solinas, GP; Tartara, A; Torre, F, 1994) |
"Treatment of phenytoin responders and nonresponders with other primary antiepileptic drugs showed that valproate and phenobarbital induced much smaller increases in focal seizure threshold in phenytoin nonresponders than in responders, whereas carbamazepine induced about the same threshold increase in both groups." | 1.29 | Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. ( Hönack, D; Löscher, W; Rundfeldt, C, 1993) |
"Authors report about a boy with Rasmussen syndrome." | 1.29 | [Rasmussen syndrome]. ( Lombay, B; Velkey, I, 1993) |
"Phenytoin has been considered a possible cause of cerebellar degeneration, especially after clinical intoxication." | 1.29 | [Cerebellar atrophy and phenytoin poisoning. An MR study]. ( Aichner, F; Bauer, G; Birbamer, G; Felber, S; Luef, G; Marosi, M, 1993) |
"Carbamazepine has no effect on the EEG, in epilepsies with atypical course (atypical benign partial epilepsy, Landau-Kleffner syndrome, epilepsy with continuous spikes and waves during slow sleep [CSWS]) carbamazepine usually has no effect either on the seizures or on the EEG, on the contrary, in some cases both may even get worse." | 1.29 | Treatment of "benign" partial epilepsies of childhood, including atypical forms. ( Gross-Selbeck, G, 1995) |
"We report an additional patient with cardiac arrest during a mesiobasal left temporal lobe seizure discharge." | 1.28 | Cardiac arrest due to partial epileptic seizures. ( Gudjonsson, O; Liedholm, LJ, 1992) |
" Its pharmacokinetic features and optimal dosage show great individual variability, larger than that of other drugs and, in cases of combined drug regimens, interactions may more frequently be expected." | 1.28 | Place of phenytoin in treatment of resistant epilepsy. ( Rajna, P; Veres, J; Vitray, J, 1991) |
"Phenytoin continues to be a very popular drug for most types of seizures, but carbamazepine, used adjunctively until recently, is effective as monotherapy for the control of partial seizures, particularly those of the complex partial variety." | 1.27 | Treatment of the nonconvulsive epilepsies. ( Dreifuss, FE, 1983) |
"Only when the epilepsy is uncontrolled despite high plasma concentrations which cannot be raised because of side effects, a second drug should be given." | 1.27 | [Pharmacotherapy of epilepsy--current problems and controversies]. ( Schmidt, D, 1983) |
"The optimal dosage of phenytoin can be accurately determined by a pharmacokinetic method." | 1.26 | Rapid metabolism of phenytoin: a method of calculating proper dosage. ( Allen, JP; Hawkins, DW; Hoffman, SF; Ludden, TM, 1979) |
"Carbamazepine levels were also slightly greater in white matter." | 1.26 | Distribution of anticonvulsant drugs in gray and white matter of human brain. ( Harvey, CD; Sherwin, AL; Van Der Kleijn, E, 1977) |
"Analysis of the recurrence of seizures suggested that the first year of treatment may be crucial in determining the long-term prognosis." | 1.26 | Early prognosis of epilepsy. ( Reynolds, EH; Shorvon, SD, 1982) |
" The dosage received by this group was from 4." | 1.26 | Plasma levels of diphenylhydantoin and the control of adult epileptic seizures: a Chilean experience. ( Aguilera, LI; Concha, GL; Droguett, PA; Galdames, DG; Morales, ER; Ortiz, MA; Saavedra, IN; Valenzuela, AL, 1980) |
" (3) Use of well-standardized, yet simplified, mental performance tests in combination with changes in the dosage of medication can help in reaching a compromise between acceptable seizure control and avoidance of excessive slowing of mental activity." | 1.25 | Effects of different dosages of anticonvulsant drugs on mental performance in patients with chronic epilepsy. ( Dekaban, AS; Lehman, EJ, 1975) |
"Benign focal epilepsy of childhood is an entity that includes characteristic clinical and electroencephalographic manifestations." | 1.25 | Benign focal epilepsy of childhood. A follow-up study of 100 recovered patients. ( Kivity, S; Lerman, P, 1975) |
"Glycine content was markedly elevated in two of 16 epileptogenic foci." | 1.25 | Amino acids in human epileptogenic foci. ( Hansen, S; Kennedy, J; Perry, TL; Thompson, GB; Wada, JA, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 100 (49.50) | 18.7374 |
1990's | 50 (24.75) | 18.2507 |
2000's | 24 (11.88) | 29.6817 |
2010's | 25 (12.38) | 24.3611 |
2020's | 3 (1.49) | 2.80 |
Authors | Studies |
---|---|
Nevitt, SJ | 6 |
Sudell, M | 3 |
Cividini, S | 1 |
Marson, AG | 16 |
Tudur Smith, C | 13 |
Rajendran, P | 1 |
Prabath, I | 1 |
Rani, J | 1 |
Sudarsan, P | 1 |
Varghese, R | 1 |
Suresh, A | 1 |
Radhakrishnan, A | 1 |
Weston, J | 6 |
Arya, R | 2 |
Giridharan, N | 1 |
Anand, V | 2 |
Garg, SK | 2 |
Ishikawa, N | 1 |
Tateishi, Y | 1 |
Tani, H | 1 |
Kobayashi, Y | 1 |
Kobayashi, M | 1 |
Kim, H | 1 |
Faught, E | 1 |
Thurman, DJ | 1 |
Fishman, J | 1 |
Kalilani, L | 1 |
Nolan, SJ | 5 |
Pulman, J | 2 |
Rubio-Nazabal, E | 1 |
Alvarez-Pérez, P | 1 |
Lema-Facal, T | 1 |
López-Facal, S | 1 |
Muller, M | 2 |
Tanaka, S | 1 |
Tanaka, T | 1 |
Habib, M | 1 |
Khan, SU | 1 |
Hoque, A | 1 |
Mondal, BA | 1 |
Hasan, AT | 1 |
Chowdhury, RN | 1 |
Haque, B | 1 |
Rahman, KM | 1 |
Chowdhury, AH | 1 |
Ghose, SK | 1 |
Mohammad, QD | 1 |
Michael, BD | 1 |
Janszky, J | 1 |
Horvath, R | 1 |
Komoly, S | 1 |
Mintzer, S | 2 |
Miller, R | 1 |
Shah, K | 1 |
Chervoneva, I | 1 |
Nei, M | 1 |
Skidmore, C | 1 |
Sperling, MR | 1 |
Mizoi, Y | 1 |
Sumita, N | 1 |
Yamamoto, T | 1 |
Komori, T | 1 |
Tamura, N | 1 |
Shimazu, K | 1 |
Bernášková, K | 1 |
Mareš, P | 3 |
Mattson, RT | 1 |
Maguire, M | 2 |
Ramaratnam, S | 2 |
Kotov, AS | 1 |
Rudakova, IG | 1 |
Baulac, S | 1 |
Ishida, S | 1 |
Mashimo, T | 1 |
Boillot, M | 1 |
Fumoto, N | 1 |
Kuwamura, M | 1 |
Ohno, Y | 1 |
Takizawa, A | 1 |
Aoto, T | 1 |
Ueda, M | 1 |
Ikeda, A | 2 |
LeGuern, E | 1 |
Takahashi, R | 1 |
Serikawa, T | 1 |
Fernández-de Orueta, L | 1 |
Esteban-Fernández, J | 1 |
Aichner, HF | 1 |
Casillas-Villamor, A | 1 |
Rodríguez-Álvarez, S | 1 |
De Marcos, FA | 1 |
Ghizoni, E | 1 |
Kobayashi, E | 1 |
Li, LM | 1 |
Cendes, F | 1 |
PRESTON, DN | 1 |
ATACK, EA | 1 |
Cramer, JA | 3 |
Hammer, AE | 1 |
Kustra, RP | 1 |
Herzog, AG | 2 |
Drislane, FW | 2 |
Schomer, DL | 2 |
Pennell, PB | 2 |
Bromfield, EB | 2 |
Kelly, KM | 1 |
Farina, EL | 2 |
Frye, CA | 2 |
Margari, L | 1 |
Lucia, M | 1 |
Presicci, A | 1 |
Anna, P | 1 |
Ventura, P | 1 |
Patrizia, V | 1 |
Buttiglione, M | 1 |
Maura, B | 1 |
Andreula, C | 1 |
Cosma, A | 1 |
Perniola, T | 1 |
Tommaso, P | 1 |
Nilsen, KE | 1 |
Walker, MC | 1 |
Cock, HR | 1 |
Arana Rueda, E | 1 |
Florián Sanz, F | 1 |
Gómez Navarro, C | 1 |
Nevado Portero, J | 1 |
Aguilera Saborido, A | 1 |
López Pardo, F | 1 |
Brodie, MJ | 2 |
Wilson, EA | 1 |
Wesche, DL | 1 |
Alvey, CW | 1 |
Randinitis, EJ | 1 |
Posvar, EL | 1 |
Hounslow, NJ | 1 |
Bron, NJ | 1 |
Gibson, GL | 1 |
Bockbrader, HN | 1 |
Williamson, PR | 3 |
Itomi, S | 1 |
Okumura, A | 2 |
Ikuta, T | 2 |
Negoro, T | 2 |
Watanabe, K | 2 |
Dworetzky, BA | 1 |
Gilbert, TH | 1 |
Teskey, GC | 1 |
Tsuge, I | 1 |
Kubota, T | 1 |
Kurahashi, H | 1 |
Natsume, J | 1 |
Lin, CJ | 1 |
Yen, MF | 1 |
Hu, OY | 1 |
Lin, MS | 1 |
Hsiong, CH | 1 |
Hung, CC | 1 |
Liou, HH | 1 |
Wilensky, AJ | 3 |
Ojemann, LM | 3 |
Temkin, NR | 1 |
Troupin, AS | 2 |
Dodrill, CB | 2 |
Strejcková, A | 1 |
Maresová, D | 1 |
Smejkalová, V | 1 |
Rowan, AJ | 1 |
Ramsay, RE | 1 |
Wilder, BJ | 3 |
Berger, JR | 1 |
Bruni, J | 4 |
Friel, PN | 1 |
Almes, MJ | 1 |
Levy, RH | 2 |
Dreifuss, FE | 2 |
McGowan, ME | 1 |
Hinge, HH | 1 |
Schmidt, D | 1 |
Turnbull, DM | 3 |
Rawlins, MD | 3 |
Weightman, D | 2 |
Chadwick, DW | 3 |
Palm, R | 1 |
Silseth, C | 1 |
Alván, G | 1 |
Wolf, P | 1 |
Röder-Wanner, UU | 1 |
Brede, M | 1 |
D'Alessandro, R | 1 |
Cortelli, P | 1 |
Gallassi, R | 1 |
Ghisoli, E | 1 |
Montanaro, N | 1 |
Zoni, E | 1 |
Baruzzi, A | 1 |
Pratt, JA | 1 |
Jenner, P | 1 |
Johnson, AL | 4 |
Shorvon, SD | 3 |
Reynolds, EH | 5 |
Mauguière, F | 2 |
Fischer, C | 1 |
Ferry, S | 2 |
Courjon, J | 2 |
Davies, SM | 1 |
Rothner, AD | 1 |
Erenberg, G | 1 |
Galdames, DG | 1 |
Saavedra, IN | 1 |
Ortiz, MA | 1 |
Aguilera, LI | 1 |
Valenzuela, AL | 1 |
Concha, GL | 1 |
Droguett, PA | 1 |
Morales, ER | 1 |
Chauplannaz, G | 1 |
Petrone, F | 1 |
Cavalcanti, S | 1 |
Turchiaro, GG | 1 |
Rolando, G | 1 |
Browne, TR | 3 |
Habedank, M | 1 |
Esser, KJ | 1 |
Brüll, D | 1 |
Kotlarek, F | 1 |
Stumpf, C | 1 |
Gibberd, FB | 3 |
Park, DM | 1 |
Scott, G | 1 |
Gawel, MJ | 1 |
Fry, DE | 1 |
Page, NG | 1 |
Engler, C | 1 |
English, JR | 1 |
Rose, FC | 1 |
Dalla Bernardina, B | 1 |
Fontana, E | 1 |
Vigevano, F | 1 |
Fusco, L | 1 |
Torelli, D | 1 |
Galeone, D | 1 |
Buti, D | 1 |
Cianchetti, C | 1 |
Gnanasakthy, A | 1 |
Iudice, A | 1 |
Gross-Selbeck, G | 1 |
Heller, AJ | 1 |
Chesterman, P | 1 |
Elwes, RD | 1 |
Crawford, P | 1 |
Chadwick, D | 1 |
Tigaran, S | 1 |
Callaghan, N | 4 |
Majeed, T | 1 |
O'Connell, A | 1 |
Oliveira, DB | 1 |
Murialdo, G | 1 |
Galimberti, CA | 1 |
Fonzi, S | 1 |
Manni, R | 1 |
Costelli, P | 1 |
Parodi, C | 1 |
Torre, F | 1 |
Solinas, GP | 1 |
Polleri, A | 1 |
Tartara, A | 1 |
Yamamoto, M | 1 |
Okudaira, A | 1 |
Kohira, I | 1 |
Kugoh, T | 1 |
Fukunishi, I | 1 |
Hosokawa, K | 1 |
Löscher, W | 4 |
Rundfeldt, C | 2 |
Hönack, D | 1 |
Velkey, I | 1 |
Lombay, B | 1 |
Bittencourt, PR | 1 |
Antoniuk, SA | 2 |
Bigarella, MM | 1 |
da Costa, JC | 1 |
Doro, MP | 1 |
Ferreira, AS | 1 |
Fonseca, LC | 1 |
Gorz, AM | 1 |
Gonçalves e Silva, GE | 1 |
Marcourakis, T | 1 |
Tsuji, M | 1 |
Hori, S | 1 |
Asai, N | 1 |
Hamanaka, T | 1 |
Ishikawa, T | 1 |
Hiyoshi, T | 1 |
Mochizuki, H | 1 |
Bauer, TM | 1 |
Brühwiler, J | 1 |
Aschwanden, M | 1 |
Wagner, S | 1 |
Schwander, J | 1 |
Luef, G | 1 |
Marosi, M | 1 |
Felber, S | 1 |
Birbamer, G | 1 |
Aichner, F | 1 |
Bauer, G | 1 |
Riley, RJ | 1 |
Smith, G | 2 |
Wolf, CR | 1 |
Cook, VA | 1 |
Leeder, JS | 1 |
Jibiki, I | 1 |
Kido, H | 1 |
Matsuda, H | 1 |
Yamaguchi, N | 1 |
Hisada, K | 1 |
de Silva, M | 1 |
MacArdle, B | 1 |
McGowan, M | 1 |
Hughes, E | 1 |
Stewart, J | 1 |
Neville, BG | 2 |
Privitera, M | 1 |
Fincham, R | 1 |
Penry, J | 1 |
Reife, R | 1 |
Kramer, L | 1 |
Pledger, G | 1 |
Karim, R | 1 |
Martínez Bermejo, Z | 1 |
Pascual-Castroviejo, I | 1 |
Kato, H | 1 |
Kishikawa, H | 1 |
Emura, S | 1 |
Takashima, T | 1 |
Ohmori, K | 1 |
Fujita, H | 1 |
Bill, PA | 1 |
Vigonius, U | 2 |
Pohlmann, H | 2 |
Guerreiro, CA | 1 |
Kochen, S | 1 |
Saffer, D | 1 |
Moore, A | 2 |
Guerreiro, MM | 1 |
de Manreza, ML | 1 |
Fejerman, N | 1 |
Pal, DK | 1 |
Das, T | 1 |
Chaudhury, G | 1 |
Kennedy, BT | 1 |
Haller, JS | 1 |
Kanner, AM | 1 |
Bourgeois, BF | 1 |
Hasegawa, H | 1 |
Hutson, P | 1 |
López-Ariztegui, N | 1 |
Ochoà, M | 1 |
Sánchez-Migallón, MJ | 1 |
Nevado, C | 1 |
Martín, M | 1 |
Gilliam, F | 1 |
Vazquez, B | 1 |
Sackellares, JC | 1 |
Chang, GY | 1 |
Messenheimer, J | 1 |
Nyberg, J | 1 |
Risner, ME | 1 |
Rudd, GD | 1 |
Hattori, H | 1 |
Odani, A | 1 |
Kimura, J | 1 |
Shibasaki, H | 1 |
Ebert, U | 3 |
Lehmann, H | 1 |
Scholz, J | 1 |
Vieregge, P | 1 |
Moser, A | 1 |
Contin, M | 1 |
Riva, R | 1 |
Albani, F | 1 |
Baruzzi, AA | 1 |
Brückner, C | 1 |
Heinemann, U | 1 |
Husain, AM | 1 |
Carwile, ST | 1 |
Miller, PP | 1 |
Radtke, RA | 1 |
Reissmüller, E | 1 |
McBride, MC | 1 |
Laroia, N | 1 |
Guillet, R | 1 |
Kmieć, T | 1 |
Jóźwiak, S | 1 |
Kuczyński, D | 1 |
Karkowska, B | 1 |
Bachański, M | 1 |
Huber, A | 1 |
Padrun, V | 1 |
Déglon, N | 1 |
Aebischer, P | 1 |
Möhler, H | 1 |
Boison, D | 1 |
Bauer, J | 1 |
Burr, W | 1 |
Taylor, S | 1 |
Friel, P | 2 |
Morretti-Ojemann, L | 1 |
Feigl, P | 2 |
Janz, D | 1 |
Kosteljanetz, M | 2 |
Christiansen, J | 3 |
Dam, AM | 2 |
Hansen, BS | 2 |
Lyon, BB | 2 |
Pedersen, H | 2 |
Dam, M | 3 |
Hawkins, DW | 1 |
Ludden, TM | 1 |
Hoffman, SF | 1 |
Allen, JP | 1 |
Iinuma, K | 1 |
Takamatsu, N | 1 |
Onuma, A | 1 |
Tada, K | 1 |
Ward, AA | 1 |
Harvey, CD | 1 |
Sherwin, AL | 2 |
Van Der Kleijn, E | 1 |
Ito, T | 1 |
Hori, M | 1 |
Yoshida, K | 1 |
Shimizu, M | 1 |
Troupin, A | 1 |
Halpern, L | 1 |
Dodrill, C | 1 |
Wilkus, R | 1 |
Kristensen, CB | 1 |
Gartside, IB | 1 |
McNaughton, FL | 1 |
Rasmussen, T | 1 |
Lerman, P | 2 |
Kivity, S | 1 |
Perry, TL | 1 |
Hansen, S | 1 |
Kennedy, J | 1 |
Wada, JA | 1 |
Thompson, GB | 1 |
Mikkelsen, B | 1 |
Birket-Smith, E | 1 |
Holm, P | 1 |
Lund, M | 1 |
Vestermark, S | 1 |
Olsen, PZ | 1 |
Sutton, G | 1 |
Kupferberg, HJ | 1 |
Dekaban, AS | 1 |
Lehman, EJ | 1 |
Mygind, KI | 1 |
Marg, E | 1 |
Hassan, MN | 1 |
Laljee, HC | 1 |
Parsonage, MJ | 1 |
Thomas, JA | 1 |
Knotts, GR | 1 |
Moses, PD | 1 |
Kirubakaran, C | 1 |
Chacko, DS | 1 |
McKee, PJ | 1 |
Percy-Robb, I | 1 |
Liedholm, LJ | 1 |
Gudjonsson, O | 1 |
Guillaume, D | 1 |
Grisar, T | 1 |
Delgado-Escueta, AV | 2 |
Laschet, J | 1 |
Bureau-Heeren, M | 1 |
Bardy, AH | 1 |
Fujikawa, Y | 1 |
Kubota, H | 1 |
Matsuda, K | 1 |
Fujiwara, T | 1 |
Yagi, K | 1 |
Seino, M | 1 |
Rastogi, P | 1 |
Mehrotra, TN | 1 |
Agarwala, RK | 1 |
Singh, VS | 1 |
al-Rubeaan, K | 1 |
Ryan, EA | 1 |
Rajna, P | 1 |
Veres, J | 1 |
Vitray, J | 1 |
Leppik, IE | 1 |
Pledger, GW | 1 |
Graves, NM | 1 |
Santilli, N | 1 |
Drury, I | 1 |
Tsay, JY | 1 |
Jacobs, MP | 1 |
Bertram, E | 1 |
Cereghino, JJ | 2 |
Herkes, GK | 1 |
Eadie, MJ | 1 |
Mak, KH | 1 |
Chee, M | 1 |
Peng, SM | 1 |
Wu, JZ | 1 |
Okura, M | 1 |
Nagamine, I | 1 |
Ishimoto, Y | 1 |
Otsuka, T | 1 |
Ogawa, Y | 1 |
O'Laoire, SA | 1 |
Shaw, MD | 1 |
Patten, SB | 1 |
Klein, GM | 1 |
Lussier, C | 1 |
Sawa, R | 1 |
Lamas Barreiro, JM | 1 |
Arsensio Fierro, F | 1 |
Salas Puig, J | 1 |
Fernández Gutiérrez, I | 1 |
de Quirós, JF | 1 |
Cornaggia, CM | 1 |
Canevini, MP | 1 |
Giuccioli, D | 1 |
Pruneri, C | 1 |
Canger, R | 1 |
Goggin, T | 3 |
Casey, C | 1 |
Nowack, WJ | 1 |
Zhu, YL | 1 |
Mukherjee, A | 2 |
Roy, T | 1 |
Faingold, CL | 1 |
Browning, RA | 1 |
Rangel, R | 1 |
Garrett, A | 1 |
Degen, R | 1 |
Degen, HE | 1 |
Kuhlmann, HP | 1 |
Ostrowska, Z | 1 |
Buntner, B | 1 |
Rościszewska, D | 1 |
Guz, I | 1 |
Abajo, FJ | 1 |
Hess, CW | 1 |
Mattson, RH | 2 |
Collins, JF | 2 |
Mulroy, JJ | 1 |
Mickell, JJ | 1 |
Tong, TK | 1 |
Pellock, JM | 1 |
Howel, D | 1 |
Gallitto, G | 1 |
Bramanti, P | 1 |
Di Rosa, AE | 1 |
Musolino, R | 1 |
De Domenico, P | 1 |
Troilo, G | 1 |
Santoro, M | 1 |
Di Perri, R | 1 |
Patsalos, PN | 1 |
Elyas, AA | 1 |
Smith, DB | 1 |
Williamson, PD | 1 |
Treiman, DM | 1 |
McNamara, JO | 1 |
McCutchen, CB | 1 |
Kenny, RA | 1 |
O'Neill, B | 1 |
Crowley, M | 1 |
Shen, DL | 1 |
Fröscher, W | 1 |
Stoll, KD | 1 |
Vining, EP | 1 |
Freeman, JM | 1 |
Laitinen, L | 1 |
Toivakka, E | 1 |
Sibley, WA | 1 |
Wisen, AA | 1 |
Sokolowski, CD | 1 |
Speciali, JG | 1 |
Lison, MP | 1 |
Billinghurst, JR | 1 |
German, GA | 1 |
Orley, JH | 1 |
Karp, M | 1 |
Doron, M | 1 |
Laron, Z | 1 |
Brock, JT | 1 |
Van Meter, JC | 1 |
Penry, JK | 1 |
Smith, LD | 1 |
Fisher, P | 1 |
Ellenberg, J | 1 |
Arseni, C | 1 |
Marinescu, V | 1 |
Edmonds, HL | 1 |
Stark, LG | 1 |
Hollinger, MA | 1 |
Takahashi, Y | 1 |
Maruko, K | 1 |
Koizumi, S | 1 |
Ueno, B | 1 |
Kumashiro, H | 1 |
Hildick-Smith, M | 1 |
Engel, E | 1 |
Böhl, I | 1 |
Schulz, H | 1 |
Kutt, H | 2 |
Louis, S | 2 |
van Duijn, H | 1 |
Visser, SL | 1 |
Dvilansky, A | 1 |
Lehman, E | 1 |
Sherwin, I | 1 |
Moss-Herjanic, B | 1 |
Viukari, NM | 1 |
Borkowska, Z | 1 |
Mazurkowa, K | 1 |
Wojakowski, A | 1 |
Kristiansen, K | 1 |
Kaada, BR | 1 |
Henriksen, GF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
PLA General Hospital[NCT05920512] | Phase 1/Phase 2 | 10 participants (Anticipated) | Interventional | 2022-04-01 | Recruiting | ||
Efficacy and Tolerability of Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy (STANDLOW). A Multicenter, Randomized, Single-blind, Parallel-group Trial[NCT03689114] | Phase 4 | 374 participants (Anticipated) | Interventional | 2020-01-07 | Not yet recruiting | ||
Antiseizure Medication-Induced Elevation of Serum Estradiol and Reproductive Dysfunction in Men With Epilepsy[NCT00179426] | 175 participants | Observational | 1999-10-31 | Completed | |||
Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome[NCT01607073] | Phase 2 | 2 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
An Open Prospective Randomised Long-Term Effectiveness Study, Comparing Best Medical Practice With or Without Adjunctive VNS Therapy in Patients 16 Years and Older With Pharmaco-resistant Partial Epilepsy[NCT00522418] | Phase 4 | 122 participants (Actual) | Interventional | 2006-02-28 | Terminated (stopped due to Insufficient enrollment) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The secondary outcome measure is the change in number of absence seizures from Week 8 (Baseline) to Week 12 (NCT01607073)
Timeframe: Week 8 to Week 12
Intervention | Abscence seizures (Number) |
---|---|
Week 8 Baseline | 165 |
Week 12 Verapamil 4mg/kg/Day | 101 |
The primary study endpoint is the change in number of seizures from baseline. Since we only had one participant finish the study, the endpoint was changed to Week 12 visit. Participants were on verapamil for 4 weeks at Week 12. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
Intervention | General tonic-clonic seizures (Number) |
---|---|
Week 8 Baseline | 39 |
Week 12 Verapamil 4mg/kg/Day | 14 |
The secondary outcome is the change in number of myoclonic seizures between baseline Week 8 visit and Week 12 visit. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
Intervention | Myoclonic seizures (Number) |
---|---|
Week 8 Baseline | 116 |
Week 12 Verapamil 4mg/kg/Day | 175 |
Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Mean change from baseline AEP Score at 12 months
Intervention | Units on a scale (Mean) |
---|---|
VNS Therapy | -6.0 |
Best Medical Practice | -3.2 |
The Center for Epidemiologic Studies Depression Scale (CES-D) includes 20 items comprising six scales reflecting major dimensions of depression: depressed mood, feelings of guilt and worthlessness, feelings of helplessness and hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance. Possible range of scores is 0 to 60, higher scores indicate more depressive symptoms. (NCT00522418)
Timeframe: Mean change from baseline CES-D Score at 12 months
Intervention | Units on a Scale (Mean) |
---|---|
VNS Therapy | -2.2 |
Best Medical Practice | 0.5 |
The Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) is a 6-item questionnaire validated to screen for depression in people with epilepsy. Scores range from 6 to 24, with higher scores indicating more depressive symptoms. (NCT00522418)
Timeframe: Mean change from baseline NDDI-E Score at 12 months
Intervention | Units on a Scale (Mean) |
---|---|
VNS Therapy | -1.0 |
Best Medical Practice | -0.2 |
Change from baseline in number of AED medications by visit (NCT00522418)
Timeframe: Change from baseline in number of AEDs at 12 months
Intervention | Number of AEDs Taken (Median) |
---|---|
VNS Therapy | 0 |
Best Medical Practice | 0 |
The Clinical Global Impression scale (CGI-I) is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention Scores range from 1-7: 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse. (NCT00522418)
Timeframe: Mean change from baseline CGI-I Score at 12 months
Intervention | Units on a Scale (Mean) |
---|---|
VNS Therapy | -0.8 |
Best Medical Practice | -0.3 |
Percent change in total seizuires per week from baseline at 12 months (NCT00522418)
Timeframe: Mean percent change from baseline in seizure frequency at 12 months
Intervention | Percent Change (Mean) |
---|---|
VNS Therapy | -19.1 |
Best Medical Practice | -1.0 |
QOLIE-89 contains 17 multi-item measures of overall quality of life, emotional well-being, role limitations due to emotional problems, social support, social isolation, energy/fatigue, worry about seizure, medication effects, health discouragement, work/driving/social function, attention/concentration, language, memory, physical function, pain, role limitations due to physical problems, and health perceptions. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. (NCT00522418)
Timeframe: Mean change from baseline QOLIE-89 Overall Score at 12 months
Intervention | units on a scale (Mean) |
---|---|
VNS Therapy | 5.5 |
Best Medical Practice | 1.2 |
Response Rate is defined as the percent of participants who are responders. A Responder is defined as participants with a reduction of at least 50% or 75% in seizure frequency from baseline to the seizure count evaluation period. (NCT00522418)
Timeframe: Number of Responders at 12 Months
Intervention | participants (Number) |
---|---|
VNS Therapy | 10 |
Best Medical Practice | 7 |
QOLIE-89 contains 17 multi-item measures of overall quality of life. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Change from baseline up to 12 months
Intervention | units on a scale (Least Squares Mean) | |
---|---|---|
VNS Therapy | Best Medical Practice | |
Baseline Adverse Event Profile Score < 40 | 3.3 | 0.5 |
QOLIE-89 contains 17 multi-item measures of overall quality of life. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Change from baseline up to 12 months
Intervention | Units on a Scale (Least Squares Mean) | |
---|---|---|
VNS Therapy | Best Medical Practice | |
Baseline Adverse Event Profile Score >= 40 | 3.3 | 0.7 |
36 reviews available for phenytoin and Abdominal Epilepsy
Article | Year |
---|---|
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Anticonvulsants; Child; Epilepsies, Partial; Epilepsy; Humans; Network Meta-Analysis; Phenyto | 2022 |
Cutaneous Hypersensitivity Reaction After Phenytoin Therapy in a Neonate: A Case Report and Review of Literature Elucidating the Potential Pharmacological Plausibility and Preventive Strategies.
Topics: Anticonvulsants; Child; Drug Hypersensitivity; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; | 2023 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti | 2017 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti | 2017 |
Clobazam monotherapy for focal or generalized seizures.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Clobazam; Epilepsies, Par | 2018 |
Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Humans; Phenytoin; Randomized Controlle | 2018 |
Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Humans; Induction Chemotherapy; Oxcarb | 2018 |
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Humans; I | 2013 |
Oxcarbazepine versus phenytoin monotherapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Induction Chemotherapy; Oxcar | 2013 |
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Phenyto | 2013 |
Clobazam monotherapy for partial-onset or generalized-onset seizures.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Clobazam; Epilepsies, Par | 2014 |
[ZONISAMIDE: FIRST CHOICE AMONG THE FIRST-LINE ANTIEPILEPTIC DRUGS IN FOCAL EPILEPSY].
Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Administratio | 2015 |
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Humans; In | 2015 |
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Phenyto | 2016 |
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Humans; In | 2017 |
Should enzyme-inducing antiepileptic drugs be considered first-line agents?
Topics: Anticonvulsants; Cholesterol; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; E | 2009 |
Epilepsy (partial).
Topics: Anticonvulsants; Clinical Trials as Topic; Cost-Benefit Analysis; Epilepsies, Partial; Epilepsy; Hum | 2010 |
Epilepsy (partial).
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy; Humans; Phenytoin; Vigabatrin | 2011 |
Oxcarbazepine versus phenytoin monotherapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Oxcarbazepine; Phenytoin; Ran | 2006 |
Diagnosis and treatment of epilepsy.
Topics: Automatism; Benzodiazepines; Carbamazepine; Electroencephalography; Epilepsies, Partial; Epilepsy; E | 1983 |
Final adult height of patients with epilepsy.
Topics: Adolescent; Adult; Age Factors; Body Height; Epilepsies, Partial; Epilepsy; Epilepsy, Tonic-Clonic; | 1983 |
Probable cerebellar abnormality on 123I-IMP SPECT scans in epileptic patients with long-term high-dose phenytoin therapy. Based on observation of multiple cases.
Topics: Adult; Amphetamines; Cerebellar Diseases; Cerebellum; Epilepsies, Partial; Female; Frontal Lobe; Fun | 1993 |
[The diagnosis and treatment of partial epilepsy in childhood and adolescence].
Topics: Age of Onset; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epile | 1996 |
[Acute phenytoin poisoning secondary to an interaction with ticlopidine].
Topics: Acute Disease; Aged; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Ataxia; Cerebrovascular Disorde | 1998 |
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Humans; Phenytoin; Randomized Controlle | 2001 |
Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Generalized; Humans; Phenobarbital; Phenytoin; Rando | 2001 |
Valproic acid. Review of a new antiepileptic drug.
Topics: Adolescent; Adult; Animals; Brain Chemistry; Drug Interactions; Electric Stimulation; Electroencepha | 1979 |
Drug therapy reviews: drug therapy of status epilepticus.
Topics: Anesthesia, General; Diazepam; Epilepsies, Partial; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epil | 1978 |
Theoretical basis for surgical therapy of epilepsy.
Topics: Animals; Cerebellum; Cerebral Cortex; Epilepsies, Partial; Haplorhini; Humans; Memory; Microelectrod | 1975 |
Mechanisms of anticonvulsant drug action. I. Drugs primarily used for generalized tonic-clonic and partial epilepsies.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Kinetics; Phenobarbital; Phen | 1987 |
Carbamazepine efficacy in adults with partial and generalized tonic-clonic seizures.
Topics: Adult; Carbamazepine; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Humans; Phenytoin | 1987 |
[Therapy of brain-related minor seizures].
Topics: Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, Myoclonic; Epilepsies, Partial; | 1988 |
Anticonvulsants, folic acid, and epilepsy.
Topics: Anemia, Macrocytic; Animals; Anticonvulsants; Blood-Brain Barrier; Chemical Phenomena; Chemistry; Ep | 1973 |
Diagnosis and treatment of epilepsy: overview and general principles.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; | 1974 |
Current drug therapy--antiepilepsy agents.
Topics: Anticonvulsants; Barbiturates; Chemical Phenomena; Chemistry; Drug Interactions; Epilepsies, Partial | 1974 |
Anticonvulsant drugs. II. Clinical pharmacological and therapeutic aspects.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Blood Coagulation Disorders; Cerebellum; Drug Interact | 1972 |
40 trials available for phenytoin and Abdominal Epilepsy
Article | Year |
---|---|
Quality of life improvement with conversion to lamotrigine monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Electroencephalography | 2004 |
Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Clinical Trials as Topic; Clorazepate Dipotassium; Doub | 1981 |
A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults.
Topics: Adolescent; Adult; Aged; Carbamazepine; Double-Blind Method; Epilepsies, Partial; Epilepsy, Tonic-Cl | 1983 |
Cinromide in epilepsy: a pilot study.
Topics: Adult; Carbamazepine; Cinnamates; Clinical Trials as Topic; Epilepsies, Partial; Female; Humans; Mal | 1983 |
Influence of therapeutic phenobarbital and phenytoin medication on the polygraphic sleep of patients with epilepsy.
Topics: Adolescent; Adult; Aged; Drug Interactions; Epilepsies, Partial; Epilepsy; Female; Humans; Male; Mid | 1984 |
A comparison of phenytoin and valproate in previously untreated adult epileptic patients.
Topics: Adolescent; Adult; Age Factors; Aged; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Humans | 1982 |
A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Clinical Trials as Topic; Double-Blind Method; Epilepsies, | 1982 |
Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study.
Topics: Anticonvulsants; Child; Child, Preschool; Data Interpretation, Statistical; Epilepsies, Partial; Fem | 1995 |
Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.
Topics: Adolescent; Adult; Aged; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; | 1995 |
Pure sensory seizures.
Topics: Carbamazepine; Cerebral Infarction; Electroencephalography; Epilepsies, Partial; Female; Functional | 1993 |
Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function.
Topics: Adolescent; Adult; Affect; Carbamazepine; Child; Cognition; Epilepsies, Partial; Epilepsy; Female; H | 1993 |
Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; | 1996 |
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carboplatin; Dose-Response Relationship, Drug; Double-Blin | 1996 |
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Double-Blind Method; Epi | 1997 |
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Double-Blind Method; Epilepsies | 1997 |
Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India.
Topics: Adolescent; Anticonvulsants; Child; Child Behavior Disorders; Child, Preschool; Developing Countries | 1998 |
Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Amines; Anti-Anxiety Agents; Anticonvulsants; | 1998 |
Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
Topics: Adolescent; Age Factors; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; C | 1998 |
An active-control trial of lamotrigine monotherapy for partial seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Double-Blind Method; Epilepsies, Partial; E | 1998 |
Gabapentin as adjunctive therapy for partial seizures.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dizziness; Dru | 1999 |
Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Chil | 1999 |
Electrographic seizures in neonates correlate with poor neurodevelopmental outcome.
Topics: Anticonvulsants; Asphyxia Neonatorum; Demography; Developmental Disabilities; Electroencephalography | 2000 |
[Gabitril as an additive drug in therapy of intractable epileptic seizures in children].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Drug Therapy, Combi | 2000 |
Evaluation of clorazepate (Tranxene) as an anticonvulsant--a pilot study.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Clorazepate Dipotassium; Dose-Resp | 1979 |
Carbamazepine vs phenytoin. A controlled clinical trial in focal motor and generalized epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epilepsies, P | 1979 |
[Carbamazepine (Tegretol) or phenytoin in the treatment of focal motor epilepsy or generalized epilepsy? A controlled clinical trial].
Topics: Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluati | 1979 |
Carbamazepine--a double-blind comparison with phenytoin.
Topics: Adult; Ataxia; Carbamazepine; Clinical Trials as Topic; Drug Evaluation; Epilepsies, Partial; Hemato | 1977 |
A controlled trial on clonazepam INN (Ro 5-4023, Rivotril (R)) in the treatment of focal epilepsy and secondary generalized grand mal epilepsy.
Topics: Adolescent; Adult; Aged; Benzodiazepinones; Child; Child, Preschool; Clinical Trials as Topic; Clona | 1975 |
Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy.
Topics: Adolescent; Adult; Child; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Male; Middle A | 1991 |
Felbamate for partial seizures: results of a controlled clinical trial.
Topics: Adult; Anticonvulsants; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Epilepsies, P | 1991 |
Post-operative epilepsy and the efficacy of anticonvulsant therapy.
Topics: Anticonvulsants; Brain Neoplasms; Carbamazepine; Epilepsies, Partial; Follow-Up Studies; Glioma; Hum | 1990 |
Serum levels of sodium valproate, phenytoin and carbamazepine and seizure control in epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; Fema | 1986 |
Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, Par | 1988 |
Aspects of compliance: taking drugs and keeping clinic appointments.
Topics: Adolescent; Adult; Anticonvulsants; Appointments and Schedules; Carbamazepine; Clinical Trials as To | 1988 |
Which drug for the adult epileptic patient: phenytoin or valproate?
Topics: Adolescent; Adult; Aged; Body Weight; Clinical Trials as Topic; Epilepsies, Partial; Epilepsy; Femal | 1985 |
The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; | 1985 |
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.
Topics: Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epilepsies, P | 1985 |
A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic; Dose-Resp | 1985 |
Evaluation of albutoin as an antiepileptic drug.
Topics: Adolescent; Adult; Allyl Compounds; Analysis of Variance; Anticonvulsants; Appetite; Biopharmaceutic | 1974 |
Diphenylhydantoin as an anticonvulsant: evaluation of treatment in forty mentally subnormal epileptics.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Electroencephalography; Epilepsies, Par | 1969 |
126 other studies available for phenytoin and Abdominal Epilepsy
Article | Year |
---|---|
Phenytoin-Induced Paradoxical Seizures and Blood Dyscrasias in a Patient Receiving Rapid Intravenous Infusion: A Case Report.
Topics: Anticonvulsants; Epilepsies, Partial; Humans; Infusions, Intravenous; Middle Aged; Phenytoin; Seizur | 2021 |
Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dizziness; Drug Resistant Epile | 2019 |
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Anxiety Disorders; Comorbidity; Dissociative Disorders; Epilepsi | 2019 |
[Othello syndrome secondary to zonisamide].
Topics: Adult; Anticonvulsants; Brain Diseases; Cysts; Delusions; Drug Substitution; Drug Therapy, Combinati | 2014 |
Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
Topics: Adult; Anticonvulsants; Benzodiazepines; Clobazam; Drug Therapy, Combination; Epilepsies, Partial; E | 2013 |
Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital.
Topics: Adolescent; Adult; Anticonvulsants; Bangladesh; Carbamazepine; Child; Drug Combinations; Epilepsies, | 2013 |
Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein.
Topics: Anticonvulsants; Biomarkers; C-Reactive Protein; Carbamazepine; Drug Substitution; Drug Therapy, Com | 2016 |
[Case of juvenile myoclonic epilepsy misdiagnosed as simple partial seizure for more than 60 years].
Topics: Aged; Cerebellar Ataxia; Diagnostic Errors; Electroencephalography; Electromyography; Epilepsies, Pa | 2009 |
Similar effects of lamotrigine and phenytoin against cortical epileptic foci in immature rats.
Topics: Age Factors; Animals; Animals, Newborn; Bicuculline; Disease Models, Animal; Dose-Response Relations | 2010 |
[Epilepsy in elderly].
Topics: Aged; Aged, 80 and over; Aging; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, | 2011 |
A rat model for LGI1-related epilepsies.
Topics: Amino Acid Sequence; Animals; Anticonvulsants; Brain; Carbamazepine; Cells, Cultured; Chlorocebus ae | 2012 |
Topiramate-induced metabolic acidosis: a case study.
Topics: Acidosis; Acidosis, Renal Tubular; Aged; Anticonvulsants; Cerebral Hemorrhage, Traumatic; Comorbidit | 2012 |
Cerebellar volume and long-term use of phenytoin.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Cerebellum; Child; Child, Preschool; Dose-Response Relatio | 2003 |
TEMPORAL LOBE EPILEPSY: A CLINICAL STUDY OF 47 CASES.
Topics: Adolescent; Biomedical Research; Birth Injuries; Depression; Depressive Disorder; Diagnosis, Differe | 1964 |
Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Estradiol; Humans; Lamotrigi | 2004 |
Congenital bilateral perisylvian syndrome with partial epilepsy. Case report with long-term follow-up.
Topics: Adolescent; Cerebral Cortex; Electroencephalography; Epilepsies, Partial; Female; Follow-Up Studies; | 2005 |
Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Diazepam; Disease Models, Animal; Electroencephal | 2005 |
[Mitral prosthetic valve and presyncope].
Topics: Anticoagulants; Anticonvulsants; Atrial Fibrillation; Diagnostic Errors; Electroencephalography; Epi | 2005 |
Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combinatio | 2005 |
Phenytoin desensitization in a child with symptomatic localization-related epilepsy.
Topics: Anticonvulsants; Child; Drug Therapy, Combination; Epilepsies, Partial; Humans; Male; Phenytoin; Pri | 2007 |
Differential effects of antiepileptic drugs on neuroactive steroids in men with epilepsy.
Topics: Adolescent; Adult; Androgens; Androstanes; Anticonvulsants; Biological Availability; Carbamazepine; | 2006 |
Conventional anticonvulsant drugs in the guinea-pig kindling model of partial seizures: effects of repeated administration.
Topics: Action Potentials; Amygdala; Animals; Anticonvulsants; Brain; Carbamazepine; Disease Models, Animal; | 2007 |
Phenytoin desensitization monitored by antigen specific T cell response using carboxyfluorescein succinimidyl ester dilution assay.
Topics: Anticonvulsants; CD4-Positive T-Lymphocytes; Child; Desensitization, Immunologic; Dose-Response Rela | 2007 |
Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy.
Topics: Adult; Alkaline Phosphatase; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pr | 2008 |
Effect of diphenylhydantoin on unit activity in a cortical epileptogenic focus in the rat.
Topics: Animals; Cerebral Cortex; Electroencephalography; Epilepsies, Partial; Male; Penicillins; Phenytoin; | 1983 |
Effect of diphenylhydantion on cortical epileptogenic foci in the rat.
Topics: Animals; Cerebral Cortex; Electroencephalography; Epilepsies, Partial; Male; Penicillins; Phenytoin; | 1983 |
Treatment of the nonconvulsive epilepsies.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Humans; Phenobarbi | 1983 |
[Status epilepticus following lumbar myelography with metrizamide (Amipaque)].
Topics: Clonazepam; Epilepsies, Partial; Female; Humans; Metrizamide; Middle Aged; Myelography; Phenytoin | 1983 |
[Pharmacotherapy of epilepsy--current problems and controversies].
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; Epilepsy, | 1983 |
"Therapeutic" serum concentration of phenytoin: the influence of seizure type.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Epilepsies, Partial; Female; Humans; Male | 1984 |
Phenytoin intoxication as the first symptom of fatal liver damage induced by sodium valproate.
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Epilepsies, Partial; Femal | 1984 |
Phenytoin-induced increase in growth hormone response to levodopa in adult males.
Topics: Adult; Epilepsies, Partial; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; | 1984 |
Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Dose-Response Relationship, Drug; Epilepsies, Myoclon | 1984 |
[Treatment of partial motor status epilepticus in adults with intravenous diphenylhydantoin (DPH). Prospective study of 50 cases].
Topics: Adult; Epilepsies, Partial; Female; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Ph | 1984 |
Epilepsy in children.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Diagnosis, Differential; Electroencephalogr | 1984 |
Status epilepticus.
Topics: Anesthesia, General; Child; Child, Preschool; Diazepam; Epilepsies, Myoclonic; Epilepsies, Partial; | 1980 |
Plasma levels of diphenylhydantoin and the control of adult epileptic seizures: a Chilean experience.
Topics: Adolescent; Adult; Aged; Chile; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Phenytoin | 1980 |
[Use of intravenous phenytoin in treatment of partial status epilepticus (author's transl)].
Topics: Adult; Epilepsies, Partial; Female; Humans; Injections, Intravenous; Male; Middle Aged; Phenytoin; S | 1981 |
[Polytherapy and monotherapy in the treatment of patients with epilepsy].
Topics: Adult; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Epilepsy, | 1981 |
Therapy of status epilepticus.
Topics: Anticonvulsants; Diazepam; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Humans; Lorazepam; Paraldehy | 1982 |
Increased sister chromatid exchanges in epileptic children during long-term therapy with phenytoin.
Topics: Adolescent; Cells, Cultured; Child; Chromosomes, Human; Crossing Over, Genetic; Epilepsies, Partial; | 1982 |
Early prognosis of epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Female; Humans; Male; | 1982 |
Treatment of "benign" partial epilepsies of childhood, including atypical forms.
Topics: Adrenocorticotropic Hormone; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinone | 1995 |
A 15-year follow-up of phenytoin-induced unilateral gingival hyperplasia: a case report.
Topics: Adult; Carbamazepine; Cerebral Infarction; Dose-Response Relationship, Drug; Epilepsies, Partial; Fe | 1994 |
A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients.
Topics: Adult; Alkaline Phosphatase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Chemical a | 1994 |
Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs.
Topics: Adult; Androstenedione; Anticonvulsants; Carbamazepine; Dihydrotestosterone; Epilepsies, Partial; Ep | 1994 |
Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy.
Topics: Amino Acids; Aminocaproates; Amygdala; Animals; Anticonvulsants; Carbamazepine; Disease Models, Anim | 1993 |
[Rasmussen syndrome].
Topics: Acyclovir; Carbamazepine; Child, Preschool; Electroencephalography; Encephalitis; Epilepsies, Partia | 1993 |
Two epileptics showing antiepileptic drug-induced psychoses.
Topics: Adolescent; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroenc | 1993 |
[Neurocysticercosis].
Topics: Albendazole; Animals; Antibodies, Helminth; Brain; Brain Diseases; Croatia; Cysticercosis; Diagnosis | 1994 |
[Cerebellar atrophy and phenytoin poisoning. An MR study].
Topics: Adult; Anticonvulsants; Atrophy; Cerebellar Ataxia; Cerebellum; Dose-Response Relationship, Drug; Dr | 1993 |
Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s)
Topics: Adult; Animals; Anticonvulsants; Autoantibodies; Autoantigens; Carbamazepine; Cell Line; Cross React | 1993 |
Treatment of focal status epilepticus with lignocaine.
Topics: Aged; Anticonvulsants; Diazepam; Epilepsies, Partial; Epilepsy, Generalized; Humans; Lidocaine; Male | 1997 |
Treatment of the epileptic patient in the dental office.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Child; Dental Care for Chronically Ill; Emergencies; Ep | 1998 |
Rapid switchover to carbamazepine using pharmacokinetic parameters.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedul | 1998 |
Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation.
Topics: Adult; Anticonvulsants; Epilepsies, Partial; Gynecomastia; Humans; Isoxazoles; Male; Metabolism, Inb | 1998 |
Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of experimental and environmental factors.
Topics: Animals; Anticonvulsants; Atmospheric Pressure; Differential Threshold; Disease Models, Animal; Drug | 1999 |
Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of genetic factors.
Topics: Animals; Anticonvulsants; Differential Threshold; Disease Models, Animal; Drug Resistance; Electroph | 1999 |
Central pain as a manifestation of partial epileptic seizures.
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsies, Partial; Female; Humans; Magnetic Resona | 1999 |
Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Carbamazepine; Entorhinal Cortex; Epilepsies, Partial; Fe | 2000 |
Improved sexual function in three men taking lamotrigine for epilepsy.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsies, Partial; | 2000 |
The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats.
Topics: Amygdala; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Resistance; Electric Stim | 2000 |
Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Aggression; Animals; Brain; Cell Line; Cell Transp | 2001 |
Course of chronic focal epilepsy resistant to anticonvulsant treatment.
Topics: Adult; Anticonvulsants; Carbamazepine; Cluster Analysis; Disease Progression; Documentation; Drug Ad | 2001 |
[Drug resistance in epilepsy therapy].
Topics: Anticonvulsants; Contraceptives, Oral; Drug Resistance; Drug Therapy, Combination; Electroencephalog | 1978 |
Rapid metabolism of phenytoin: a method of calculating proper dosage.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy, Tonic-Cl | 1979 |
Childhood epilepsy uncontrolled by phenytoin: clinical and electroencephalographic study.
Topics: Adolescent; Child; Child, Preschool; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy | 1979 |
Distribution of anticonvulsant drugs in gray and white matter of human brain.
Topics: Anticonvulsants; Brain; Carbamazepine; Epilepsies, Partial; Humans; Mesencephalon; Nervous System; P | 1977 |
Effect of anticonvulsants on cortical focal seizure in cats.
Topics: Acetazolamide; Animals; Anticonvulsants; Carbamazepine; Cats; Diazepam; Electrocardiography; Epileps | 1977 |
One-sided gingival hyperplasia after treatment with diphenylhydantoin.
Topics: Adult; Epilepsies, Partial; Female; Gingival Hyperplasia; Humans; Phenytoin; Pregnancy; Pregnancy Co | 1977 |
The actions of diazepam and phenytoin on a low dose penicillin epileptiform focus in the anaesthetised rat.
Topics: Animals; Diazepam; Electroencephalography; Epilepsies, Partial; Penicillin G; Phenytoin; Rats | 1978 |
Criteria for selection of patients for neurosurgical treatment.
Topics: Adolescent; Age Factors; Child; Electroencephalography; Encephalitis; Epilepsies, Partial; Epilepsy; | 1975 |
Benign focal epilepsy of childhood. A follow-up study of 100 recovered patients.
Topics: Adolescent; Child; Drug Therapy, Combination; Electroencephalography; Epilepsies, Partial; Female; F | 1975 |
Amino acids in human epileptogenic foci.
Topics: Adolescent; Adult; Amino Acids; Animals; Aspartic Acid; Cerebral Cortex; Child; Cystathionine; Epile | 1975 |
Diseases of the central nervous system: Epilepsy.
Topics: Age Factors; Diazepam; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Eth | 1975 |
Isoniazid as an inhibitor of primidone metabolism.
Topics: Depression, Chemical; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Isoniazid; Mid | 1975 |
Effects of different dosages of anticonvulsant drugs on mental performance in patients with chronic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Chronic Disease; Dose-Response Relationship, Drug; Epilep | 1975 |
Phenytoin and phenobarbitone plasma clearance during pregnancy.
Topics: Adult; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Female; Human | 1976 |
[Stevens-Johnson syndrome as an early allergic reaction to diphenylhydantoin].
Topics: Adult; Drug Hypersensitivity; Epilepsies, Partial; Humans; Male; Phenytoin; Stevens-Johnson Syndrome | 1976 |
Sodium valproate in the treatment of resistant epilepsy.
Topics: Adolescent; Adult; Alopecia; Anticonvulsants; Body Weight; Diarrhea; Drug Interactions; Epilepsies, | 1976 |
Epilepsy and other seizure disorders in children: drug management.
Topics: Acetazolamide; Anticonvulsants; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, T | 1976 |
Disappearing CT lesions in focal seizures.
Topics: Brain Diseases; Child; Cysticercosis; Epilepsies, Partial; Female; Humans; Phenytoin; Praziquantel; | 1992 |
Therapeutic drug monitoring improves seizure control and reduces anticonvulsant side-effects in patients with refractory epilepsy.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Monitoring; Electroencephalog | 1992 |
Cardiac arrest due to partial epileptic seizures.
Topics: Adult; Electrocardiography; Electroencephalography; Epilepsies, Partial; Female; Heart Arrest; Human | 1992 |
Phosphorylation of brain (Na+,K+)-ATPase alpha catalytic subunits in normal and epileptic cerebral cortex: II. Partial seizures in human epilepsy.
Topics: Brain; Catalysis; Cerebral Cortex; Electrophoresis, Polyacrylamide Gel; Epilepsies, Partial; Epileps | 1991 |
[Diagnosis of petit mal attack].
Topics: Adult; Diagnosis, Differential; Epilepsies, Partial; Epilepsy, Absence; Humans; Phenytoin | 1990 |
Reversal of MRI lesion with relapse and remission of partial motor seizures in epilepsia partialis continua.
Topics: Adolescent; Anticonvulsants; Cerebral Cortex; Drug Therapy, Combination; Electroencephalography; Epi | 1991 |
Phenytoin-induced insulin insensitivity.
Topics: Aged; Aged, 80 and over; C-Peptide; Coronary Artery Bypass; Coronary Disease; Epilepsies, Partial; H | 1991 |
Place of phenytoin in treatment of resistant epilepsy.
Topics: Adolescent; Adult; Aged; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Male; Middle Aged; | 1991 |
Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Female; Humans; Male; Menstrua | 1990 |
Focal seizure in non-ketotic hyperglycaemia.
Topics: Aged; Blood Glucose; Brain Diseases; Diabetes Mellitus, Type 2; Epilepsies, Partial; Female; Humans; | 1990 |
[High-dose monotherapy in intractable epilepsy].
Topics: Adolescent; Adult; Carbamazepine; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy; Female; Huma | 1990 |
Evoked potentials of self-interrupted Jacksonian epilepsy.
Topics: Aged; Electroencephalography; Epilepsies, Partial; Evoked Potentials, Auditory; Evoked Potentials, S | 1990 |
Epilepsy following neurosurgical intervention.
Topics: Anticonvulsants; Craniotomy; Epilepsies, Partial; Humans; Intracranial Aneurysm; Phenytoin; Postoper | 1990 |
Organic mania induced by phenytoin: a case report.
Topics: Aged; Bipolar Disorder; Cerebral Infarction; Epilepsies, Partial; Female; Humans; Mental Status Sche | 1989 |
[Insulinoma, complex partial seizures and diphenylhydantoin].
Topics: Adenoma, Islet Cell; Electroencephalography; Epilepsies, Partial; Female; Humans; Insulinoma; Middle | 1987 |
Carbamazepine, phenytoin and phenobarbital in drug-resistant partial epilepsies.
Topics: Adolescent; Adult; Carbamazepine; Drug Evaluation; Drug Resistance; Epilepsies, Partial; Epilepsy, T | 1986 |
Adult onset stuttering and seizures.
Topics: Adult; Combined Modality Therapy; Electroencephalography; Epilepsies, Partial; Female; Humans; Pheny | 1986 |
[Clinical application of the measurement of serum phenytoin sodium (DPH) concentrations].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Femal | 1986 |
Phenytoin encephalopathy.
Topics: Child; Encephalitis; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Humans; Male; Phenytoin | 1986 |
[Rolandi epilepsy--a frequent seizure disorder in childhood. Symptomatology, electroencephalography, etiology, therapy, prognosis].
Topics: Adolescent; Carbamazepine; Child; Drug Therapy, Combination; Electroencephalography; Epilepsies, Par | 1988 |
Adrenal cortex hormones in male epileptic patients before and during a 2-year phenytoin treatment.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adrenal Cortex Hormones; Adult; Epilepsies, Partial; Epil | 1988 |
Phenytoin interaction with rifampicin.
Topics: Aged; Aged, 80 and over; Drug Interactions; Epilepsies, Partial; Humans; Male; Phenytoin; Rifampin; | 1988 |
Postictal pulmonary edema in children.
Topics: Carbamazepine; Child; Epilepsies, Partial; Furosemide; Humans; Intubation, Intratracheal; Male; Oxyg | 1985 |
Diphenylhydantoin encephalopathy. A case report.
Topics: Adult; Dose-Response Relationship, Drug; Electroencephalography; Epilepsies, Partial; Evoked Potenti | 1985 |
[Single daily dose of diphenylhydantoin in treating epilepsy].
Topics: Adolescent; Adult; Child; Drug Administration Schedule; Epilepsies, Partial; Epilepsy, Tonic-Clonic; | 1985 |
[Antiepileptic monotherapy and combination therapy of simple focal seizures].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Clonazepam; Drug Therapy, Combination; Ele | 1985 |
Where, why, and what type of therapy.
Topics: Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Hum | 1985 |
Clonazepam (Ro 5-4023) in the treatment of myoclonus epilepsy. Four case reports.
Topics: Adult; Anticonvulsants; Benzodiazepinones; Chlorobenzenes; Diazepam; Drug Therapy, Combination; Elec | 1973 |
Anticonvulsant drugs in human epileptogenic brain. Correlation of phenobarbital and diphenylhydantoin levels with plasma.
Topics: Adolescent; Adult; Aged; Animals; Biopsy; Cerebral Cortex; Child; Electroencephalography; Epilepsies | 1973 |
[Undesirable effect of antiepileptic therapy in a patient with epilepsy and maturational focal discharges].
Topics: Cerebral Cortex; Child, Preschool; Electroencephalography; Epilepsies, Partial; Epilepsy, Absence; H | 1973 |
The pattern of epilepsy in Uganda.
Topics: Adolescent; Adult; Age Factors; Black People; Child; Child, Preschool; Electroencephalography; Epile | 1973 |
Effect of diphenylhydantoin on insulin response in the oral glucose tolerance test in children and adolescents.
Topics: Administration, Oral; Adolescent; Age Factors; Child; Epilepsies, Partial; Epilepsy, Tonic-Clonic; F | 1973 |
Epilepsy in cerebral hydatidosis.
Topics: Adolescent; Adult; Brain Diseases; Child; Child, Preschool; Dominance, Cerebral; Echinococcosis; Ele | 1974 |
The effects of diphenylhydantoin, phenobarbital, and diazepam on the penicillin-induced epileptogenic focus in the rat.
Topics: Animals; Autoradiography; Brain; Carbon Radioisotopes; Diazepam; Disease Models, Animal; Electroence | 1974 |
Syndromes of Sturge-Weber and Klippel-Weber in the same patient.
Topics: Adolescent; Angiomatosis; Bone Diseases; Electromyography; Epilepsies, Partial; Humans; Leukocyte Co | 1974 |
Epilepsy in the elderly.
Topics: Age Factors; Aged; Angiography; Brain Neoplasms; Cerebrovascular Disorders; Dementia; Electroencepha | 1974 |
[Outpatient therapy of epilepsy].
Topics: Anticonvulsants; Barbiturates; Depression, Chemical; Drug Eruptions; Drug Hypersensitivity; Epilepsi | 1970 |
Epilepsy.
Topics: Adult; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, T | 1969 |
Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects.
Topics: Acetates; Acetazolamide; Anticonvulsants; Carbamazepine; Diazepam; Dibenzazepines; Electroencephalog | 1972 |
The action of some anticonvulsant drugs on cobalt-induced epilepsy and on the bemegride threshold in alert cats.
Topics: Animals; Anticonvulsants; Bemegride; Carbamazepine; Cats; Cobalt; Diazepam; Electroencephalography; | 1972 |
Megaloblastic anemia after anticonvulsive therapy.
Topics: Adult; Anemia, Macrocytic; Anticonvulsants; Epilepsies, Partial; Humans; Male; Phenobarbital; Phenyt | 1972 |
Suppressant effects of diphenylhydantoin on the cortical epileptogenic focus.
Topics: Animals; Cats; Cerebral Cortex; Disease Models, Animal; Electric Stimulation; Electroencephalography | 1973 |
Prolonged unconsciousness following electroconvulsive therapy.
Topics: Adult; Aged; Coma; Craniocerebral Trauma; Depression; Electroconvulsive Therapy; Epilepsies, Partial | 1967 |
[Results of treatment of epilepsy in children up to 14 years of age].
Topics: Adolescent; Age Factors; Barbiturates; Child; Child, Preschool; Diazepam; Drug Synergism; Electroenc | 1971 |
Epilepsia partialis continua.
Topics: Adult; Brain Diseases; Brain Stem; Electroencephalography; Epilepsies, Partial; Epilepsy; Hematoma, | 1971 |